Global NSCLC Market Dynamics and Innovations: Striving to Transform Lung Cancer Treatment
05 sept. 2023 09h51 HE
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Global NSCLC Market Dynamics and Innovations: Striving to Transform Lung Cancer Treatment
05 sept. 2023 09h49 HE
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
United States Squamous-Cell Carcinoma of the Esophagus Epidemiology Report 2022-2042
26 mai 2023 07h28 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Squamous-Cell Carcinoma of the Esophagus in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ...
United States Squamous-Cell Carcinoma of the Larynx Epidemiology Report 2022-2042
26 mai 2023 07h08 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Squamous-Cell Carcinoma of the Larynx in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ...
United States Squamous-Cell Carcinoma of the Oral Cavity Epidemiology Report 2022-2042
25 mai 2023 10h38 HE
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Squamous-Cell Carcinoma of the Oral Cavity in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ...
Privo Technologies, Inc. Announces Positive Results From Phase 1/2 Clinical Trial for PRV111 in Head and Neck Squamous Cell Carcinoma
22 oct. 2021 13h39 HE
|
Privo Technologies
PEABODY, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Privo Technologies, Inc. ("Privo"), announced today the positive results of their Phase 1/2 clinical trial examining their lead asset PRV111 in...
Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies
29 avr. 2021 20h30 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, April 29, 2021 (GLOBE NEWSWIRE) -- Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies A comprehensive analysis of...